Short Interest in Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Declines By 53.1%

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) saw a significant decline in short interest in July. As of July 31st, there was short interest totaling 4,819 shares, a decline of 53.1% from the July 15th total of 10,281 shares. Currently, 0.9% of the shares of the company are sold short. Based on an average daily volume of 105,236 shares, the days-to-cover ratio is presently 0.0 days.

Defiance Daily Target 2X Long LMND ETF Stock Performance

Shares of NASDAQ:LMNX traded down $0.93 during midday trading on Monday, reaching $7.99. 27,871 shares of the company traded hands, compared to its average volume of 47,865. The firm’s fifty day moving average price is $13.80 and its two-hundred day moving average price is $16.96. The firm has a market capitalization of $4.39 million, a price-to-earnings ratio of 15.67 and a beta of -18.70. The company has a quick ratio of 6.08, a current ratio of 8.37 and a debt-to-equity ratio of 0.52. Defiance Daily Target 2X Long LMND ETF has a 12 month low of $6.90 and a 12 month high of $55.00.

Defiance Daily Target 2X Long LMND ETF Company Profile

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.